Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMA

Accurate genetic diagnosis is necessary for guiding the treatment of spinal muscular atrophy (SMA). An updated consensus for the diagnosis and management of SMA was published in 2018. However, clinicians should remain alert to some pitfalls of genetic testing that can occur when following a routine...

Full description

Bibliographic Details
Main Authors: Yujin Qu, Jinli Bai, Hui Jiao, Hong Qi, Wenchen Huang, Shijia OuYang, Xiaoyin Peng, Yuwei Jin, Hong Wang, Fang Song
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024040465
_version_ 1797224152355045376
author Yujin Qu
Jinli Bai
Hui Jiao
Hong Qi
Wenchen Huang
Shijia OuYang
Xiaoyin Peng
Yuwei Jin
Hong Wang
Fang Song
author_facet Yujin Qu
Jinli Bai
Hui Jiao
Hong Qi
Wenchen Huang
Shijia OuYang
Xiaoyin Peng
Yuwei Jin
Hong Wang
Fang Song
author_sort Yujin Qu
collection DOAJ
description Accurate genetic diagnosis is necessary for guiding the treatment of spinal muscular atrophy (SMA). An updated consensus for the diagnosis and management of SMA was published in 2018. However, clinicians should remain alert to some pitfalls of genetic testing that can occur when following a routine diagnosis. In this study, we report the diagnosis of three unrelated individuals who were initially misdiagnosed as carrying a homozygous deletion of SMN1 exon 7. MLPA (P060 and P021) and qPCR were used to detect the copy number of SMN. SMN1 variants were identified by SMN1 clone and next-generation sequencing (NGS). Transcription of SMN1 variants was detected using qRT-PCR and ex vivo splicing analysis. Among the three individuals, one was identified as a patient with SMA carrying a heterozygous deletion and a pathogenic variant (c.835-17_835-14delCTTT) of SMN1, one was a healthy carrier only carrying a heterozygous deletion of SMN1 exon 7, and the third was a patient with nemaline myopathy 2 carrying a heterozygous deletion of SMN1 exon 7. The misdiagnosis of these individuals was attributed to the presence of the c.835-17_835-14delCTTT or c.835-17C > G variants in SMN1 intron 6, which affect the amplification of SMN1 exon 7 during MLPA-P060 and qPCR testing. However, MLPA-P021 and NGS analyses were unaffected by these variants. These results support that additional detection methods should be employed in cases where the SMN1 copy number is ambiguous to minimize the misdiagnosis of SMA.
first_indexed 2024-04-24T13:48:34Z
format Article
id doaj.art-b844da04ae9f4896a4351e47954502f1
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-24T13:48:34Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-b844da04ae9f4896a4351e47954502f12024-04-04T05:06:38ZengElsevierHeliyon2405-84402024-03-01106e28015Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMAYujin Qu0Jinli Bai1Hui Jiao2Hong Qi3Wenchen Huang4Shijia OuYang5Xiaoyin Peng6Yuwei Jin7Hong Wang8Fang Song9Department of Medical Genetics, Capital Institute of Pediatrics, Beijing, ChinaDepartment of Medical Genetics, Capital Institute of Pediatrics, Beijing, ChinaDepartment of Neurology, Children’s Hospital Affiliated to Capital Institute of Pediatrics, Beijing, ChinaPrenatal Diagnosis Center, Beijing Haidian District Maternal and Child Health Care Hospital, Beijing, ChinaDepartment of Medical Genetics, Capital Institute of Pediatrics, Beijing, ChinaDepartment of Medical Genetics, Capital Institute of Pediatrics, Beijing, ChinaDepartment of Neurology, Children’s Hospital Affiliated to Capital Institute of Pediatrics, Beijing, ChinaDepartment of Medical Genetics, Capital Institute of Pediatrics, Beijing, ChinaDepartment of Medical Genetics, Capital Institute of Pediatrics, Beijing, ChinaDepartment of Medical Genetics, Capital Institute of Pediatrics, Beijing, China; Corresponding author. Department of Medical Genetics, Capital Institute of Pediatrics, Room 521, Research Building, No. 2 Ya Bao Road, Chao Yang District, Beijing, 100020, China.Accurate genetic diagnosis is necessary for guiding the treatment of spinal muscular atrophy (SMA). An updated consensus for the diagnosis and management of SMA was published in 2018. However, clinicians should remain alert to some pitfalls of genetic testing that can occur when following a routine diagnosis. In this study, we report the diagnosis of three unrelated individuals who were initially misdiagnosed as carrying a homozygous deletion of SMN1 exon 7. MLPA (P060 and P021) and qPCR were used to detect the copy number of SMN. SMN1 variants were identified by SMN1 clone and next-generation sequencing (NGS). Transcription of SMN1 variants was detected using qRT-PCR and ex vivo splicing analysis. Among the three individuals, one was identified as a patient with SMA carrying a heterozygous deletion and a pathogenic variant (c.835-17_835-14delCTTT) of SMN1, one was a healthy carrier only carrying a heterozygous deletion of SMN1 exon 7, and the third was a patient with nemaline myopathy 2 carrying a heterozygous deletion of SMN1 exon 7. The misdiagnosis of these individuals was attributed to the presence of the c.835-17_835-14delCTTT or c.835-17C > G variants in SMN1 intron 6, which affect the amplification of SMN1 exon 7 during MLPA-P060 and qPCR testing. However, MLPA-P021 and NGS analyses were unaffected by these variants. These results support that additional detection methods should be employed in cases where the SMN1 copy number is ambiguous to minimize the misdiagnosis of SMA.http://www.sciencedirect.com/science/article/pii/S2405844024040465Spinal muscular atrophyMisdiagnosisVariantGenetic diagnosisCarrier screening
spellingShingle Yujin Qu
Jinli Bai
Hui Jiao
Hong Qi
Wenchen Huang
Shijia OuYang
Xiaoyin Peng
Yuwei Jin
Hong Wang
Fang Song
Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMA
Heliyon
Spinal muscular atrophy
Misdiagnosis
Variant
Genetic diagnosis
Carrier screening
title Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMA
title_full Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMA
title_fullStr Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMA
title_full_unstemmed Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMA
title_short Variants located in intron 6 of SMN1 lead to misdiagnosis in genetic detection and screening for SMA
title_sort variants located in intron 6 of smn1 lead to misdiagnosis in genetic detection and screening for sma
topic Spinal muscular atrophy
Misdiagnosis
Variant
Genetic diagnosis
Carrier screening
url http://www.sciencedirect.com/science/article/pii/S2405844024040465
work_keys_str_mv AT yujinqu variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT jinlibai variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT huijiao variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT hongqi variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT wenchenhuang variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT shijiaouyang variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT xiaoyinpeng variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT yuweijin variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT hongwang variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma
AT fangsong variantslocatedinintron6ofsmn1leadtomisdiagnosisingeneticdetectionandscreeningforsma